Mechanisms by which fibroblast growth factor 20 improves motor performance in a mouse model of Parkinson’s disease

Genome-wide studies have reported that Parkinson’s disease is associated with abnormal expression of various growth factors. In this study, male C57BL/6 mice aged 10 weeks were used to establish Parkinson’s disease models using an intraperitoneal injection of 60 mg/kg 1-methyl-4-phenyl-1,2,3,6-tetra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ai-Qin, Kong, Li-Na, Meng, Ming-Zhu, Zhao, Xiu-He, Chen, Si, Wang, Xiao-Tang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524521/
https://www.ncbi.nlm.nih.gov/pubmed/30964070
http://dx.doi.org/10.4103/1673-5374.253527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524521/
https://www.ncbi.nlm.nih.gov/pubmed/30964070
http://dx.doi.org/10.4103/1673-5374.253527

Ejemplares similares